The RBM Partnership to End Malaria, together with the Government of Uganda, convened a three-day Strategic Dialogue in Kampala from 23 to 25 March 2026. The purpose was to define a coordinated action framework to move new malaria tools faster from approval to country use.
On the sidelines of the Dialogue, the RBM Partnership CEO visited Quality Chemicals Industries Limited (QCIL), the National Medical Stores, and Uganda Virus Research Institute / Target Malaria to learn more about the country's manufacturing capacity, supply chain systems, and innovations.
